About us Contacts Drug interactions: 390 212
Drug search by name

Addyi and Procardia XL

Determining the interaction of Addyi and Procardia XL and the possibility of their joint administration.

Check result:
Addyi <> Procardia XL
Relevance: 24.08.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

NIFEdipine may increase the blood levels of flibanserin. In some cases, this may increase the risk of side effects such as drowsiness and decreases in blood pressure that can lead to dizziness, lightheadedness, fainting, and accidental injury. You should take flibanserin at bedtime to minimize the risk of these effects. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

MONITOR: Coadministration with weak inhibitors of CYP450 3A4 may increase the plasma concentrations of flibanserin, which is primarily metabolized by CYP450 3A4 and, to a lesser extent, by CYP450 2C19. In a meta-analysis of 17 oral contraceptive users and 91 non-users in Phase 1 studies, flibanserin peak plasma concentration (Cmax) and systemic exposure (AUC) were 30% and 40% higher, respectively, in oral contraceptive users than in non-users. Ethinyl estradiol, specifically, is a known weak inhibitor of CYP450 3A4 and 2C19, although other ingredients in oral contraceptives such as progestins are known substrates of CYP450 3A4 and may also be weak inhibitors. The clinical significance of this interaction is unknown. However, multiple weak CYP450 3A4 inhibitors could conceivably produce clinically relevant increases in flibanserin concentrations that may potentiate the risk of hypotension, syncope, and central nervous system depression.

MANAGEMENT: Caution is advised when flibanserin is used with multiple weak CYP450 3A4 inhibitors. Patients should be monitored for signs and symptoms of hypotension, syncope, and central nervous system depression.

References
  • "Product Information. Addyi (flibanserin)." Sprout Pharmaceuticals, Raleigh, NC.
Addyi

Generic Name: flibanserin

Brand name: Addyi

Synonyms: n.a.

Procardia XL

Generic Name: nifedipine

Brand name: Adalat CC, Procardia, Procardia XL, Afeditab CR, Nifediac CC, Nifedical XL, Adalat

Synonyms: n.a.

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle
Disease interaction